secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantheus Holdings, Inc. (LNTH)
CIK:        0001521036
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001193125-25-013841
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantheus to acquire Evergreen Theragnostics for $250M upfront plus up to $752.5M in milestones
--------------------------------------------------------------------------------

- Upfront cash consideration $250M; potential milestone payments up to $752.5M based on OCTEVY and pipeline products.
- Evergreen adds radiopharmaceutical CDMO manufacturing infrastructure and registrational-stage NET diagnostic OCTEVY.
- Transaction expected to close in second half of 2025, subject to regulatory clearances and customary conditions.
- Lantheus reaffirms FY2024 revenue guidance of $1.51B-$1.52B and adjusted EPS of $6.65-$6.70.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1521036/000119312525013841/0001193125-25-013841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1521036/000119312525013841/d925405d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-013841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer